| Structure |
Chemical Name |
CAS |
MF |
 |
(+/-)12-HETE |
71030-37-0 |
C20H32O3 |
 |
(5E,8E,11E,13E)-15-hydroxyicosa-5,8,11,13-tetraenoic acid |
73180-00-4 |
C20H32O3 |
 |
(5Z,8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoic acid |
183509-22-0 |
C20H32O3 |
 |
(5Z,8Z,10E,12R,14Z)-12-hydroperoxyicosa-5,8,10,14-tetraenoic acid |
|
C20H32O4 |
 |
(5Z,8Z,11R,12E,14Z)-11-hydroperoxyicosa-5,8,12,14-tetraenoic acid |
|
C20H32O4 |
 |
(5Z,8S,9E,11Z,14Z)-8-hydroperoxyicosa-5,9,11,14-tetraenoic acid |
|
C20H32O4 |
 |
5-KETE-D7 |
|
C20H23D7O3 |
 |
(+/-)15-HETE |
73836-87-0 |
C20H32O3 |
 |
10-HETE |
|
|
 |
19-hydroxy-5,8,11,14-eicosatetraenoic acid |
79551-85-2 |
C20H32O3 |
 |
8,15-Dihydroxy-5,8,11,14-icosatetraenoic acid |
|
C20H32O4 |
|
|
9(S)-HETE-d8 |
|
|
 |
(+/-)12-HPETE |
71030-35-8 |
C20H32O4 |
 |
(inverted exclamation markA)15-HETE-d8 |
2525175-31-7 |
C20H24D8O3 |
 |
5(S)-HPEPE |
143292-98-2 |
C20H30O4 |
 |
(8)S-HEPE |
118492-81-2 |
C20H30O3 |
 |
9(S)-HEPE |
141545-44-0 |
C20H30O3 |
 |
11(R)-HEPE |
109430-11-7 |
C20H30O3 |
 |
(5Z,8R,9R,10E,12S)-8-acetyl-9-formyl-12-hydroxyheptadeca-5,10-dienoic acid |
91712-41-3 |
C20H32O5 |
 |
(+/-)8,9-EET |
81246-85-7 |
C20H32O3 |
 |
(5Z,9E,11R,12S,14Z)-8,11,12-trihydroxyicosa-5,9,14-trienoic acid |
68860-46-8 |
C20H34O5 |
 |
11R(12S)-EET |
123931-38-4 |
C20H32O3 |
 |
5(S)-HEPE |
92008-51-0 |
C20H30O3 |
 |
HEPOXILIN A3 |
|
C20H32O4 |
 |
(+/-)5-HEPE |
83952-40-3 |
C20H30O3 |
 |
10(R,S)-HYDROXY-11(S),12(S)-TRANS-EPOXYEICOSA-5Z,8Z,14Z-TRIENOIC ACID |
94161-10-1 |
C20H32O4 |
 |
trioxilin B4 |
103301-71-9 |
C20H32O5 |
|
|
11S(12R)-EET |
|
|
 |
(+/-)-12-HYDROXY-5Z,8Z,10E,14Z,17Z-EICOSAPENTAENOIC ACID |
81187-21-5 |
C20H30O3 |
 |
(+/-)14,15-EPOXYEICOSA-5Z,8Z,11Z-TRIENOIC ACID |
81276-03-1 |
C20H32O3 |
 |
12(S)-HEPE |
116180-17-7 |
C20H30O3 |
 |
hepoxilin A4 |
103188-13-2 |
C20H30O4 |
 |
14(S),15(R)-EPOXY-(5Z,8Z,11Z)-EICOSATRIENOIC ACID |
98103-48-1 |
C20H32O3 |
 |
11(S)-HEPE |
156473-26-6 |
C20H30O3 |
|
|
trioxilin B3 |
|
|
|
|
5R(6S)-EET |
|
|
 |
(+/-)-15-HYDROXY-5Z,8Z,11Z,13E,17Z-EICOSAPENTAENOIC ACID |
88852-33-9 |
C20H30O3 |
 |
12(R)-HEPE |
109430-12-8 |
C20H30O3 |
 |
(+/-)11,12-EPOXYEICOSA-5Z,8Z,14Z-TRIENOIC ACID |
81276-02-0 |
C20H32O3 |
 |
trioxilin A4 |
103301-70-8 |
C20H32O5 |
|
|
5S(6R)-EET |
|
|
 |
15(S)-HPEPE |
125992-60-1 |
C20H30O4 |
 |
8(R),9(S)-EET |
129172-62-9 |
C20H32O3 |
 |
(+/-)-9-HYDROXY-5Z,7E,11Z,14Z,17Z-EICOSAPENTAENOIC ACID |
286390-03-2 |
C20H30O3 |
 |
12(S)-HPEPE |
103239-14-1 |
C20H30O4 |
 |
(5Z,8R,9R,10E,12S)-9-acetyl-8-formyl-12-hydroxyheptadeca-5,10-dienoic acid |
|
C20H32O5 |
 |
(+/-)-18-HYDROXY-5Z,8Z,11Z,14Z,16E-EICOSAPENTAENOIC ACID |
141110-17-0 |
C20H30O3 |
 |
15(S)-HEPE |
86282-92-0 |
C20H30O3 |
 |
(+/-)-11-HYDROXY-5Z,8Z,12E,14Z,17Z-EICOSAPENTAENOIC ACID |
99217-78-4 |
C20H30O3 |
 |
hepoxilin B4 |
103188-12-1 |
C20H30O4 |
|
|
8(S),9(R)-EET |
123931-39-5 |
|
 |
(+/-)5,6-EPOXYEICOSA-8Z,11Z,14Z-TRIENOIC ACID |
87173-80-6 |
C20H32O3 |
|
|
15(S)-HEPE-d5 |
2750534-74-6 |
|
 |
(+/-)-8-HYDROXY-5Z,9E,11Z,14Z,17Z-EICOSAPENTAENOIC ACID |
99217-77-3 |
C20H30O3 |
![(Z)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(E)-3-oxooct-1-enyl]cyclopentyl]hept-5-enoic acid](/CAS/GIF/191919-01-4.gif) |
(Z)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(E)-3-oxooct-1-enyl]cyclopentyl]hept-5-enoic acid |
191919-01-4 |
C20H32O5 |
 |
Resolvin D5 |
578008-43-2 |
C22H32O4 |
 |
(5E,7E,14Z)-10-Chloro-12-hydroxy-9-oxoprosta-5,7,10,14-tetren-1-oic acid methyl ester |
100295-80-5 |
C21H29ClO4 |
 |
(5E,7Z,14Z)-10-Chloro-12-hydroxy-9-oxoprosta-5,7,10,14-tetren-1-oic acid methyl ester |
100295-79-2 |
|
 |
Prostaglandin E1 Impurity 4 |
21003-46-3 |
C20H34O5 |
 |
CIS-7,10,13,16,19-DOCOSA-PENTAENOIC ACID |
24880-45-3 |
C22H34O2 |
![(Z)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dienyl]cyclopentyl]hept-5-enoic acid](/CAS/GIF/7045-31-0.gif) |
(Z)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dienyl]cyclopentyl]hept-5-enoic acid |
7045-31-0 |
C20H32O5 |
 |
7,10,13,16-Docosatetraenoic acid |
2091-25-0 |
C22H36O2 |
 |
Claviridenone b |
85700-44-3 |
C25H34O7 |
 |
(4R,5E,7E,12S,14Z)-4,12,20-Tris(acetyloxy)-9-oxo-5,7,10,14-prostatetren-1-oic acid methyl ester |
88216-92-6 |
|
 |
17(S)-HpDoHE |
123673-33-6 |
C22H32O4 |
 |
(+/-) 16, 17-DIHDPE |
|
C22H34O4 |
 |
Resolvin E1-d4 |
|
C20H26D4O5 |
|
|
17(S)-HDHA-d5 |
|
|
 |
clavulone II |
85700-43-2 |
C25H34O7 |
 |
17-keto-7(Z),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid Exclusive |
1233715-33-7 |
C22H32O3 |
 |
(13(14)-DiHDPA |
1345275-24-2 |
C22H34O4 |
![7-[(1S,2S)-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-1-cyclopent-3-enyl]heptanoic acid](/CAS/20200331/GIF/CB31235659.gif) |
7-[(1S,2S)-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-1-cyclopent-3-enyl]heptanoic acid |
|
C20H32O4 |
 |
(4R,5Z,7E,12S,14Z)-4,12-Bis(acetyloxy)-9-oxoprosta-5,7,10,14-tetren-1-oic acid methyl ester |
85700-42-1 |
C25H34O7 |
 |
(+/-)19,20-DIHDOPE |
|
C22H34O4 |
 |
chlorovulone I |
100295-81-6 |
C21H29ClO4 |
|
|
5S,9ALPHA-11ALPHA-TRIHYDROXY-(12 ALPHA)-PROSTA 6E,14Z-DIEN-1-OIC-16,16,17, 17,18,18,19,19,20,20,20-D11 ACID |
|
C20H23D11O5 |
 |
Resolvin E4 |
1781227-87-9 |
C20H30O4 |
 |
Punaglandin 4 |
96055-66-2 |
C25H35ClO8 |
 |
(4R,5E,7Z,12S,14Z)-4,12,20-Tris(acetyloxy)-9-oxo-5,7,10,14-prostatetren-1-oic acid methyl ester |
88216-93-7 |
|
 |
(4R,5Z,7E,12S,14Z)-4,12,20-Tris(acetyloxy)-9-oxo-5,7,10,14-prostatetren-1-oic acid methyl ester |
88216-91-5 |
C27H36O9 |
 |
EGREGIACHLORIDE B |
152607-08-4 |
C18H29ClO3 |
 |
10,13,16-Docosatrienoic acid |
1946-20-9 |
C22H38O2 |
 |
(+/-)19(20)-EPOXY-4Z,7Z,10Z,13Z,16-DOCOSAPENTAENOIC ACID |
|
C22H32O3 |
 |
Punaglandin 1 |
96055-63-9 |
C27H37ClO10 |
 |
ent-PGE2 |
65085-69-0 |
C20H32O5 |
 |
(-)-Claviridenone a |
85611-86-5 |
C25H34O7 |
 |
Resolvin E1 |
552830-51-0 |
C20H30O5 |
 |
8,12-iso-iPF2.alpha.-VI |
1445349-99-4 |
C20H34O5 |
 |
8-EPI PROSTAGLANDIN F2ALPHA-D4 |
|
C20H30D4O5 |
![(Z)-7-[(1S,2R,3R)-3-hydroxy-5-oxo-2-[(E)-3-oxooct-1-enyl]cyclopentyl]hept-5-enoic acid](/CAS/GIF/914804-63-0.gif) |
(Z)-7-[(1S,2R,3R)-3-hydroxy-5-oxo-2-[(E)-3-oxooct-1-enyl]cyclopentyl]hept-5-enoic acid |
914804-63-0 |
C20H30O5 |
 |
(4Z,7R,8E,10Z,12E,14E,17S,19Z)-7,16,17-trihydroxydocosa-4,8,10,12,14,19-hexaenoic acid |
82864-77-5 |
C22H32O5 |
 |
(5Z,7Z,14Z)-10-Chloro-12-hydroxy-9-oxoprosta-5,7,10,14-tetren-1-oic acid methyl ester |
100201-69-2 |
C21H29ClO4 |
 |
7,10,13,15-Docosatetraenoic acid, 17-hydroxy-, (7Z,10Z,13Z,15E,17S)- |
105835-39-0 |
C22H36O3 |
 |
7S,8R,17R-TRIHYDROXY-4Z,9E,11E,13Z,15E19Z-DOCOSAHEXAENOIC ACID |
528583-91-7 |
C22H32O5 |
 |
17(S)-HDoHE |
92693-03-3 |
C22H32O3 |
 |
Resolvin D4 |
1025684-60-9 |
C22H32O5 |
 |
17(R)-HDOHE |
155976-53-7 |
C22H32O3 |
 |
(+/-)16(17)-EPOXY-4Z,7Z,10Z,13Z,19Z-DOCOSAPENTAENOIC ACID |
|
C22H32O3 |
 |
Resolvin E2 |
865532-70-3 |
C20H30O4 |
 |
(10(11)-DiHDPA |
1345275-22-0 |
C22H34O4 |